These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
460 related items for PubMed ID: 20091495
21. Immunosuppressive treatment of AA amyloidosis of familial Mediterranean fever. Korkmaz C. Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S107-8. PubMed ID: 16273776 [No Abstract] [Full Text] [Related]
22. AA amyloidosis complicating the hereditary periodic fever syndromes. Lane T, Loeffler JM, Rowczenio DM, Gilbertson JA, Bybee A, Russell TL, Gillmore JD, Wechalekar AD, Hawkins PN, Lachmann HJ. Arthritis Rheum; 2013 Apr; 65(4):1116-21. PubMed ID: 23280696 [Abstract] [Full Text] [Related]
23. [Remission of nephrotic syndrome caused by renal amyloidosis secondary to pulmonary tuberculosis after tuberculostatic treatment]. Castellano I, Gómez-Martino JR, Hernández MT, Novillo R, Covarsí A. Nefrologia; 2001 Apr; 21(1):88-91. PubMed ID: 11344968 [Abstract] [Full Text] [Related]
24. The effect of etanercept on a case of amyloidosis secondary to ankylosing spondylitis: results of 2-year follow-up. Yilmaz H, Kocabas H, Erkin G. Acta Reumatol Port; 2013 Apr; 38(4):299-301. PubMed ID: 24435036 [Abstract] [Full Text] [Related]
25. [Amyloidosis in familial mediterranean fever: clinical and renal-biopsy features (author's transl)]. Brass H, Klein H, Buss H, Lapp H, Heintz R, Angelkort B. Dtsch Med Wochenschr; 1976 Feb 06; 101(6):200-4. PubMed ID: 1248398 [Abstract] [Full Text] [Related]
27. Anti-TNF therapy in renal amyloidosis in refractory rheumatoid arthritis: a new therapeutic perspective. Nobre CA, Callado MR, Rodrigues CE, de Menezes DB, Vieira WP. Rev Bras Reumatol; 2010 Feb 06; 50(2):205-10. PubMed ID: 21125155 [Abstract] [Full Text] [Related]
29. Efficacy of etanercept in patients with AA amyloidosis secondary to rheumatoid arthritis. Nakamura T, Higashi S, Tomoda K, Tsukano M, Baba S. Clin Exp Rheumatol; 2007 Feb 06; 25(4):518-22. PubMed ID: 17888205 [Abstract] [Full Text] [Related]
30. Effectiveness of etanercept vs cyclophosphamide as treatment for patients with amyloid A amyloidosis secondary to rheumatoid arthritis. Nakamura T, Higashi S, Tomoda K, Tsukano M, Shono M. Rheumatology (Oxford); 2012 Nov 06; 51(11):2064-9. PubMed ID: 22879465 [Abstract] [Full Text] [Related]
31. Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response. Verine J, Mourad N, Desseaux K, Vanhille P, Noël LH, Beaufils H, Grateau G, Janin A, Droz D. Hum Pathol; 2007 Dec 06; 38(12):1798-809. PubMed ID: 17714761 [Abstract] [Full Text] [Related]
32. Renal amyloidosis followed more than 5 years: report of 12 cases. Kaaroud H, Boubaker K, Béji S, Abderrahim E, Moussa FB, Turki S, Goucha R, Hedri H, El Younsi F, Kheder A, Maiz HB. Transplant Proc; 2004 Dec 06; 36(6):1796-8. PubMed ID: 15350480 [Abstract] [Full Text] [Related]
34. [Response to anti-TNF-alpha treatment for secondary renal amyloidosis in a patient with ankylosing spondylitis]. Bellissimo S, Ferrucci MG, Gallo A, Stisi S. Reumatismo; 2007 Dec 06; 59(3):240-3. PubMed ID: 17898885 [Abstract] [Full Text] [Related]
35. Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still's disease. Serratrice J, Granel B, Disdier P, Weiller PJ, Dussol B. Am J Med; 2003 Nov 06; 115(7):589-90. PubMed ID: 14599647 [No Abstract] [Full Text] [Related]
40. [Primary amyloidosis associated to severe factor X deficiency]. Pérez Martínez J, Llamas F, López Montes A, Massó P, Poblet E, López Rubio E, Gallego E, Gómez Roldán C. Nefrologia; 2004 Nov 06; 24(5):493-8. PubMed ID: 15648909 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]